Skip to main content
Clinical Trials/NCT04752085
NCT04752085
Completed
Not Applicable

Prognosis and Course of COVID-19 Infection in Hospitalised Patients

I.M. Sechenov First Moscow State Medical University2 sites in 1 country345 target enrollmentNovember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
I.M. Sechenov First Moscow State Medical University
Enrollment
345
Locations
2
Primary Endpoint
Need in biological therapy or/and respiratory support
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of the cohort prospective observational study is to define the major factors influencing the course of COVID-19 infections and its prognosis in hospitalised patients.

The investigators plan to include 300 patients hospitalised with COVID-19 infection.

The phone contacts with patients are due after 90 and 180 days after discharge.

Registry
clinicaltrials.gov
Start Date
November 1, 2020
End Date
January 10, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Olga Mironova

Associate Professor

I.M. Sechenov First Moscow State Medical University

Eligibility Criteria

Inclusion Criteria

  • Hospitalisation with COVID-19

Exclusion Criteria

  • History of hospitalisation with COVID-19 infection
  • Discharge from the hospital before the end of the treatment course
  • Transfer to another hospital

Outcomes

Primary Outcomes

Need in biological therapy or/and respiratory support

Time Frame: Up to 1 month

The primary endpoint is the need in biological therapy or/and respiratory support including noninvasive ventilation during hospital stay

Secondary Outcomes

  • Number of days spent in hospital(Up to 1 month)
  • All-cause death(180 days)

Study Sites (2)

Loading locations...

Similar Trials